Investors are on the edge of their collective seats, hoping that Nucor
What analysts say:
- Buy, sell, or hold?: Analysts are bullish on this stock with eight analysts rating it as a buy and only one rating it as a sell. Analysts like Nucor better than competitor Gerdau overall. Wall Street has warmed to the stock over the past three months, with analysts increasing their endorsement from hold to moderate buy.
- Revenue Forecasts: On average, analysts predict $4.87 billion in revenue this quarter. That would represent a rise of 17.6% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of $0.50 per share. Estimates range from $0.44 to $0.55.
What our community says:
CAPS All-Stars are solidly behind the stock with 97.5% assigning it an "outperform" rating. The community at large concurs with the All-Stars with 96.6% granting it a rating of "outperform." Fools are gung-ho about Nucor and haven't been shy with their opinions lately, logging 647 posts in the past 30 days. Nucor has a bullish CAPS rating of five out of five stars that is about on par with the Fool community assessment.
The company increased its gross margin by 5.7 percentage points in the last quarter. Revenue rose 21.7% while cost of sales rose 14.2% to $4.44 billion from a year earlier.
One final thing: If you want to keep tabs on Nucor movements, and for more analysis on the company, make sure you add it to your watchlist.
Motley Fool newsletter services have recommended buying shares of Nucor. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.